The CAQ mourns the slow memory Module in the folder of the abortion pill

Archival Photo Andréanne Lemire
“I fell down my chair when I saw that it still wasn’t set!” has launched Lise Lavallée, the mna caquiste of Repentigny and spokesperson in the field of public health.

Elisa Cloutier

Monday, December 11, 2017 15:40

UPDATE
Monday, December 11, 2017 15:45

Look at this article

The Coalition avenir Québec (CAQ) request that the minister of Health Gaétan Barrette is waiting to give the green light to the marketing of the abortion pill in Quebec, the only canadian province where it is still impossible to have access to it.

• READ ALSO: The abortion pill still not available in the province

“He [the minister Gaétan Barrette] had given so much assurance that this would be done during the announcement in July. I fell down my chair when I saw that it still wasn’t set!” lance Lise Lavallée, the mna caquiste of Repentigny and spokesperson in the field of public health. “You don’t understand. This is another folder among the others who are not making progress,” critique-t-elle.

The Journal revealed on Sunday that the abortion pill, which must be available in Québec by the “end of autumn”, is still far away from market, so that neither the College of physicians or the College of pharmacists of Quebec, who are involved in the record – claimed to have submitted its list of recommendations to the ministry of Health. The spokesperson of the College Leslie Labranche argues, however, that this will be done during the “next few days”.

In an email exchange with The Journal, the press attaché to the minister Barrette, Catherine W. Audet, merely referred to as “autumn ends on 21 December 2017, the announcement will be made at the time and place”.

“Unfortunate for women”

“It’s unfortunate for women because it would solve certain situations where they are certain that they do not want to prolong their pregnancy. Why not act now? Because going to an abortion, it’s another step,” said Ms. Lavallee.

Pharmacists and doctors

According to the recent recommendations of Health Canada, the abortion pill Mifegymiso may be provided directly to patients by a pharmacist or by another health professional authorized to prescribe it, which is of concern to the QAC. “We had taken a position for it to pass by a doctor, because the pregnancy is advanced, to ensure that all goes well. But, obviously, nothing is advanced,” says the mp, who will try to get more details from the minister of Health.

Health Canada has also announced that it is not mandatory for health professionals to follow a training to be able to prescribe the abortion pill. It will not be taken in front of the doctor. However, the rules surrounding its marketing and its distribution must be determined by the provinces.